Dr. Francisco Ward named Chief Medical Officer of Bazelet Health Systems
09 April 2021 - 2:30AM
InvestorsHub NewsWire
COLUMBIA, MD -- April 8, 2021 -- InvestorsHub NewsWire
-- Neon Bloom, Inc. (OTC:
NBCO) -- Bazelet Health Systems, Inc. ("BHS") introduces Board
Certified Dr. Francisco Ward as their new chief medical
officer (CMO). Dr. Ward is a DEA licensed physician, graduate
of Johns Hopkins School of Medicine and founder of Seton
Pain & Rehabilitation Center. Dr. Ward has worked with
the Maryland Board of Physicians and the DEA successfully
for many years and combines trusted traditional medical background
with substantial eloquence on the human endocannabinoid system,
"ECS" and the cannabinoid landscape.
Dr. Francisco Ward, graduate of Johns Hopkins School
of Medicine named Chief Medical Officer of Bazelet Health
Systems.
Dr. Ward, working from the Company's Columbia,
Maryland medical offices will be responsible for the execution
of Bazelet's healthcare programs, clinical research, and patient
experience standards. As CMO, Dr. Ward will manage relationships
with US healthcare entities, insurers, regulators and the global
medical and research community.
Selected as a greater Baltimore region "Top Doc", Dr.
Ward has served as Maryland State Medical Society chair of the
medical cannabis Task Force. His expert understanding of the
endocannabinoid system, the musculoskeletal system and its
influences on other body systems align with Bazelet Health's
priorities.
David Grand, Director of Research for Bazelet states "I am
excited and confident in Dr. Ward. His substantial knowledge and
experience as a practitioner and as a healthcare board member, is
trusted to run Bazelet Health's medical practice. Dr. Ward will
lead BHS on its deliberate strategy of effective medical treatment
and patient experience through exceptional phyto-genetics, clinical
research and reimagined, patient centered healthcare."
"Dr. Ward brings over 25 years medical knowledge, healthcare
leadership, and patient care experience. Those skillsets and being
well learned in the human ECS and cannabinoids make Dr. Ward well
suited to lead a modern-day healthcare company like Bazelet Health.
We are pleased to welcome him to our organization." Said
Bazelet co-founder and Medical Director Steven Salsburg,
MD.
About Neon Bloom, Inc.
Neon Bloom, Inc. wholly owns Bazelet Health Systems, Inc. (BHS).
BHS is the global forefront of the legal cannabis industry and
represents a deliberate strategy to create a centralized focus on
effecÂtive medical treatment and healthcare through exceptional
genetics, research, and education.
Disclaimer:
This Press Release is for informational purposes, contains
forward-looking statements based on current expectations,
forecasts, and assumptions with information available to us as of
the date hereof and involve risks and uncertainties. This Press
Release does not constitute an offer to sell or a solicitation of
offers to buy any securities of any entity. Actual results may
differ materially from those stated or implied in such
forward-looking statements. Forward-looking statements include
statements regarding our expectations, beliefs, intentions or
strategies regarding the future and can be identified by
forward-looking words such as "anticipate," "believe," "could,"
"estimate," "expect," "intend," "may," "should," "would" or similar
words. We assume no obligation to update the information included
in this Press Release, whether a result of new information, future
events or otherwise.
CONTACT: Robyn Frick
PHONE: (321) 430-0404 ext. 2105
EMAIL: support@bazelethealth.com
WEBSITE: www.bazelethealth.com
SOURCE Bazelet Health
Neon Bloom (PK) (USOTC:NBCO)
Historical Stock Chart
From Jan 2025 to Feb 2025
Neon Bloom (PK) (USOTC:NBCO)
Historical Stock Chart
From Feb 2024 to Feb 2025
